
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
EHR Deputy Delivery Manager for Research & Innovation, University College London Hospitals NHS Foundation Trust
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.